The DOI matches its Crossref record.
High-sensitive troponin T measurements: what do we gain and what are the challenges?
Abstract
Cardiac troponin (cTn) I and T are structural proteins unique to the heart. Detection of cTn in peripheral blood indicates cardiomyocyte damage. As acute myocardial infarction (AMI) is the most important cause of cardiomyocyte damage, cTns have become an integral part in the diagnosis of AMI. For this indication, cTns are superior to all other biomarkers and therefore are the preferred marker for the diagnosis of AMI. However, cTn indicates and provides an estimate of cardiomyocyte damage irrespective of its cause. The major limitation of contemporary cTn assays is that they are often not elevated during the initial hours of AMI. Recent advances in assay technology have led to more sensitive and precise cTn assays that will have a profound impact on clinical practice. High-sensitive cTn (hs-cTn) assays have two differentiating features from contemporary cTn assays: (i) detection of cTn in a majority of healthy persons and (ii) precise definition of what is 'normal' (=the 99th percentile). Recent multicentre studies have shown that hs-cTn assays improve the early diagnosis of patients with suspected AMI, particularly the early rule-out. To achieve best clinical use, cTn has to be interpreted as a quantitative variable. Rising and/or falling levels differentiate acute from chronic cardiomyocyte damage. The terms 'troponin-positive' and 'troponin negative' should therefore be avoided. 'Detectable' levels will become the norm and will have to be differentiated from 'elevated' levels. The differential diagnosis of a small amount of cardiomyocyte damage and therefore minor elevations of cTn is broad and includes acute and chronic cardiac disorders. The differential diagnosis of larger amount of injury and therefore more substantial elevations of cTn is largely restricted to AMI, myocarditis, and a rare patient with tako-tsubo cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Universal Definition of Myocardial Infarction: Clinical Insights
Paiva, L., Providência, R., Barra, S., Dinis, P., Faustino, A. C., & Gonçalves, L. (2015) · Cardiology · doi:10.1159/000371739 · Cited by 2,513
Cullen, L., Mueller, C., Parsonage, W. A., Wildi, K., Greenslade, J. H., Twerenbold, R., Aldous, S., Meller, B., Tate, J. R., Reichlin, T., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.078 · Cited by 317
Self-citationTroponin in diabetic patients with and without chronic coronary artery disease
Segre, C. A. W., Hueb, W., Garcia, R. M. R., Rezende, P. C., Favarato, D., Strunz, C. M. C., Sprandel, M. D. C. O., Roggério, A., Carvalho, A. L. D. O., Maranhão, R. C., et al. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0051-z · Cited by 42
Metadata
- Authors
- Twerenbold, R., Jaffe, A., Reichlin, T., Reiter, M., & Mueller, C.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-19
- Volume
- 33
- Issue
- 5
- Pages
- 579-586
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2098201134
- Cited by
- 217
- References
- 0
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-sensitive troponin T measurements: what do we gain and what are the challenges? https://app.cochat.ai/papers/10.1093/eurheartj/ehr492
- The paper
- Twerenbold, R., Jaffe, A., Reichlin, T., Reiter, M., & Mueller, C. (2012). High-sensitive troponin T measurements: what do we gain and what are the challenges? European Heart Journal. https://doi.org/10.1093/eurheartj/ehr492
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.